All In MedTech

Device Trial Radar · NCT03756012

Evaluation of Clinical Outcomes of Pulse Widths in Spinal Cord Stimulation

Multi-Center Evaluation of Clinical Outcomes of Pulse Widths <500 μsec and >1000 μsec During a Temporary Spinal Cord Stimulation Trial

Last checked: Nov 19, 2026Latest source record: Mar 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

15

Actual

Start

Nov 27, 2018

Primary completion

Oct 2, 2019

Study completion Oct 2, 2019

Sponsor

Lead sponsor
Kettering Health NetworkAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Ohio Pain Clinic
First posted
Nov 28, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effect of pulse widths \<500 μsec and \>1000 μsec on clinical outcomes during a temporary SCS trial.

Conditions

  • Back Pain
  • Pain

Interventions

  • Algovita Spinal Cord Stimulation SystemDevice

    The Algovita™ SCS system is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain and leg pain.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effect of Pulse Widths on Pain Clinical OutcomesTime frame: For 7 days following intervention

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Ohio Pain Clinic

    Centerville, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.